Course Report: DBS for Movement Disorders, London

Course Description

More than 100,000 patients worldwide have been treated by deep brain stimulation (DBS) for a drug refractory movement disorder. General neurologists will increasingly be confronted with the management of these patients, who suffer from chronic neurological conditions, such as Parkinson’s disease, requiring lifelong care.

This course instructed general neurologists on how to identify the cause of clinical problems in DBS-treated patients which result from either the underlying disease, inappropriate adjustment of medication and stimulation, or stimulation itself. It also discussed the selection criteria for surgery necessary to consult appropriate candidates and to refer these patients to surgical centers.

Learning Objectives

At the conclusion of this activity, participants were able to accomplish the following:

  • Provide an overview of the selection process of candidates for deep brain stimulation (DBS) in movement disorders – especially Parkinson’s disease, dystonia, and tremor – and outline the efficacy and associated risks for DBS. This includes knowledge about the different brain targets used for DBS and their effects on specific symptoms
  • Discuss the different electrical parameters that can be adjusted for DBS and outline their biological effect
  • Describe the strategies for adjustment of medication and DBS settings, especially for Parkinson’s disease, and discuss common therapy associated problems, hardware related problems, and troubleshooting strategies
  • Explain the role of the neurologist in the long-term management of patients with DBS

Recommended Audience

This course is intended for Movement Disorder specialists, general neurologists and trainees who want to become involved in the selection or postoperative management of patients with movement disorders (tremor, dystonia, Parkinson’s disease, etc.) treated by deep brain stimulation surgery.

For more information contact: MDS Education

Financial Support

This course is supported by unrestricted educational grants from:

Boston Scientific